ETFs that hold BioMarin Pharmaceutical Inc
31 US listed ETFs hold BioMarin Pharmaceutical Inc. GNOM holds the most, at 3.41% of the fund.
Every fund that holds it
| Fund | Name | Share of the fund | Holdings filed |
|---|---|---|---|
| GNOM | Global X Genomics & Biotechnology ETF | 3.41% | Sep 18, 2026 |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 3.35% | Sep 18, 2026 |
| PBE | Invesco Biotechnology & Genome ETF | 2.74% | Sep 19, 2026 |
| GNMX | Corgi Genomics & Precision Medicine ETF | 2.22% | Sep 18, 2026 |
| INVN | Alger Russell Innovation ETF | 1.99% | Jun 30, 2026 |
| BBP | Virtus Biotech ETF | 1.62% | Apr 30, 2026 |
| BBH | VanEck Biotech ETF | 1.31% | Sep 17, 2026 |
| HTEC | ROBO Global(R) Healthcare Technology and Innovation ETF | 1.27% | Apr 30, 2026 |
| BMED | iShares Health Innovation Active ETF | 1.21% | Sep 17, 2026 |
| XBI | State Street SPDR S&P Biotech ETF | 1.11% | Sep 17, 2026 |
| IBB | iShares Biotechnology ETF | 0.90% | Sep 17, 2026 |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.83% | Sep 19, 2026 |
| WDNA | WisdomTree BioRevolution Fund | 0.44% | Jun 30, 2026 |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | 0.36% | Aug 31, 2026 |
| IJH | iShares Core S&P Mid-Cap ETF | 0.36% | Sep 17, 2026 |
| MDY | SPDR S&P MidCap 400 ETF Trust | 0.36% | Sep 17, 2026 |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 0.24% | Jan 31, 2026 |
| VHT | Vanguard Health Care ETF | 0.16% | Aug 31, 2026 |
| VB | Vanguard Morningstar Small-Cap ETF | 0.15% | Aug 31, 2026 |
| VXF | Vanguard Extended Market ETF | 0.15% | Aug 31, 2026 |
| PEXL | Pacer US Export Leaders ETF | 0.10% | Apr 30, 2026 |
| IWD | iShares Russell 1000 Value ETF | 0.03% | Sep 17, 2026 |
| ONEQ | Fidelity Nasdaq Composite Index ETF | 0.02% | May 31, 2026 |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.02% | Sep 17, 2026 |
| IWB | iShares Russell 1000 ETF | 0.02% | Sep 17, 2026 |
| VTI | Vanguard Morningstar Total Stock Market ETF | 0.02% | Aug 31, 2026 |
| AVUS | Avantis U.S. Equity ETF | 0.02% | May 31, 2026 |
| SCHX | Schwab U.S. Large-Cap ETF | 0.02% | May 31, 2026 |
| DFUS | Dimensional U.S. Equity Market ETF | 0.01% | Apr 30, 2026 |
| SCHB | Schwab U.S. Broad Market ETF | 0.01% | Jun 30, 2026 |
| VT | Vanguard Total World Stock Index ETF | 0.01% | Aug 31, 2026 |
What this counts
BioMarin Pharmaceutical Inc (ticker BMRN) is matched across every holdings book ETFIQ publishes, by its ticker together with its name. A share of the fund is the weight the issuer itself published, as of the date in the last column. Option contracts, swaps, futures, cash and money market holdings are not counted as holding a company: a fund holding a call option on a share does not hold the share. Funds whose published book is gross exposure rather than a portfolio are left out entirely, because a weight in such a book is not a share of anything.
Holdings change. Each row carries the date the fund last filed, and a fund that files quarterly can have traded since.
Cite this page. ETFIQ, ETFs holding BioMarin Pharmaceutical Inc, data as of Sep 21, 2026. https://etfiq.com/holdings/bmrn/ Free to use with attribution; the underlying files are at Open data.